Uquifa

SONEAS Chemicals Ltd. provides a range of chemistry services to support pharmaceutical development, including the production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company specializes in custom synthesis at both laboratory and pilot plant scales, offering services such as route selection, safety evaluation, process optimization, and validation. Additional capabilities include the preparation of impurities and reference standards, stability studies, analytical method development, and impurity profiling. SONEAS also conducts high-temperature reactions, hydrogenations, and various other chemical processes. Founded in 1996 and based in Budapest, Hungary, SONEAS operates with a team of 144 professionals across two facilities. One site is dedicated to research and development, while the other, an 8,000 square meter cGMP-approved pilot plant, supports commercial-scale production of starting materials and intermediates for pharmaceutical and non-pharmaceutical applications. The company serves a diverse customer base, including notable names in the pharmaceutical industry. SONEAS Chemicals Ltd. was previously known as Ubichem Research Ltd. and is a subsidiary of Union Quimico Farmacéutica, S.A.